Changes in invasive aspergillosis and candidiasis epidemiology;Évolution de 1'épidérmiologie des candidoses et aspergilloses invasives

Medecine et Maladies Infectieuses

Volumn 37, Issue SUPPL. 2, 2007, Pages 2-4

  Kibbler, C ^a  

^a NONE

Author keywords

Aspergillosis; Candidiasis; Epidemiology; Invasive fungal infections; Mycoses

Indexed keywords

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDEMIA; CANDIDIASIS; INFECTION RISK; INFECTION SENSITIVITY; MYCOSIS;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS, INVASIVE; DRUG RESISTANCE, FUNGAL; FUNGEMIA; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MORBIDITY; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC;

EID: 35048843682     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/S0399-077X(07)80051-5     Document Type: Article

References (9)

1. Pagano L., Caira M., Candoni A., Offidani M., Fianchi L., Martino B., et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. The Hematology Journal 91 (2006) 1068-1075
2. Torres H., Rivero G., Lewis R., Hachem R., Raad I., and Kontoyiannis D. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn Microbiol infect Dis 46 (2003) 25-28
3. Pfaller M., and Diekema D. Epidemiology of invasive candidiadis:a persistant public health problem. Clin Microbiol Review 20 (2007) 133-163
4. Tortorano A., Peman J., Bernhardt H., Klingspor L., Klibber C., Faure O., et al. Epidemiology of candidaemia in Europe: results of 28 month European Confederation of Medical Mycology ( ECMM) Hospital-Based Surveillance Study. Eur J Clin Microbiol Infect Dis 23 (2004) 317-322
5. Tortnrano A., Kibbler C., Peman L., Bernhardt H., Klingspor L., and Grillot R. Candidaemia in Europe: epidemiology and resistance. lnt J Antimicrob Agents 27 (2006) 359-366
6. Marr K. lnvasive Candida infections: the changing epidemiology. Oncology 18 (2004), Williston Park 9-14
7. Pfaller M., Diekema D., Jones R., Sader H., Fluit A., Hollis R., et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 39 (2001) 3254-3259
8. Messer S., Jones R., and Fritsche T. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Anti- microbial Surveillance Program (2003). J Clin Microbiol. 44 (2006) 1782-1787
9. Herbrecht R., Fltickiger V., Gachot B., Ribaud P., Thiebaut A., and Cordonnier C. Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients. Eur J Cancer 5 2 (2007) 49-59